Cargando…

Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis

Muscular dystrophies are genetic diseases characterized by chronic inflammation and fibrosis. Macrophages are immune cells that sustain muscle regeneration upon acute injury but seem deleterious in the context of chronic muscle injury such as in muscular dystrophies. Here, we observed that the numbe...

Descripción completa

Detalles Bibliográficos
Autores principales: Saclier, Marielle, Angelini, Giuseppe, Bonfanti, Chiara, Mura, Giada, Temponi, Giulia, Messina, Graziella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322546/
https://www.ncbi.nlm.nih.gov/pubmed/35297529
http://dx.doi.org/10.1002/path.5895
_version_ 1784756331588091904
author Saclier, Marielle
Angelini, Giuseppe
Bonfanti, Chiara
Mura, Giada
Temponi, Giulia
Messina, Graziella
author_facet Saclier, Marielle
Angelini, Giuseppe
Bonfanti, Chiara
Mura, Giada
Temponi, Giulia
Messina, Graziella
author_sort Saclier, Marielle
collection PubMed
description Muscular dystrophies are genetic diseases characterized by chronic inflammation and fibrosis. Macrophages are immune cells that sustain muscle regeneration upon acute injury but seem deleterious in the context of chronic muscle injury such as in muscular dystrophies. Here, we observed that the number of macrophages expressing the transcription factor Nfix increases in two distinct mouse models of muscular dystrophies. We showed that the deletion of Nfix in macrophages in dystrophic mice delays the establishment of fibrosis and muscle wasting, and increases grasp force. Macrophages lacking Nfix expressed more TNFα and less TGFβ1, thus promoting apoptosis of fibro‐adipogenic progenitors. Moreover, pharmacological treatment of dystrophic mice with a ROCK inhibitor accelerated fibrosis through the increase of Nfix expression by macrophages. Thus, we have identified Nfix as a macrophage profibrotic factor in muscular dystrophies, whose inhibition could be a therapeutic route to reduce severity of the dystrophic disease. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
format Online
Article
Text
id pubmed-9322546
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-93225462022-07-30 Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis Saclier, Marielle Angelini, Giuseppe Bonfanti, Chiara Mura, Giada Temponi, Giulia Messina, Graziella J Pathol Original Articles Muscular dystrophies are genetic diseases characterized by chronic inflammation and fibrosis. Macrophages are immune cells that sustain muscle regeneration upon acute injury but seem deleterious in the context of chronic muscle injury such as in muscular dystrophies. Here, we observed that the number of macrophages expressing the transcription factor Nfix increases in two distinct mouse models of muscular dystrophies. We showed that the deletion of Nfix in macrophages in dystrophic mice delays the establishment of fibrosis and muscle wasting, and increases grasp force. Macrophages lacking Nfix expressed more TNFα and less TGFβ1, thus promoting apoptosis of fibro‐adipogenic progenitors. Moreover, pharmacological treatment of dystrophic mice with a ROCK inhibitor accelerated fibrosis through the increase of Nfix expression by macrophages. Thus, we have identified Nfix as a macrophage profibrotic factor in muscular dystrophies, whose inhibition could be a therapeutic route to reduce severity of the dystrophic disease. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. John Wiley & Sons, Ltd 2022-04-13 2022-07 /pmc/articles/PMC9322546/ /pubmed/35297529 http://dx.doi.org/10.1002/path.5895 Text en © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Saclier, Marielle
Angelini, Giuseppe
Bonfanti, Chiara
Mura, Giada
Temponi, Giulia
Messina, Graziella
Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis
title Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis
title_full Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis
title_fullStr Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis
title_full_unstemmed Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis
title_short Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis
title_sort selective ablation of nfix in macrophages attenuates muscular dystrophy by inhibiting fibro‐adipogenic progenitor‐dependent fibrosis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322546/
https://www.ncbi.nlm.nih.gov/pubmed/35297529
http://dx.doi.org/10.1002/path.5895
work_keys_str_mv AT sacliermarielle selectiveablationofnfixinmacrophagesattenuatesmusculardystrophybyinhibitingfibroadipogenicprogenitordependentfibrosis
AT angelinigiuseppe selectiveablationofnfixinmacrophagesattenuatesmusculardystrophybyinhibitingfibroadipogenicprogenitordependentfibrosis
AT bonfantichiara selectiveablationofnfixinmacrophagesattenuatesmusculardystrophybyinhibitingfibroadipogenicprogenitordependentfibrosis
AT muragiada selectiveablationofnfixinmacrophagesattenuatesmusculardystrophybyinhibitingfibroadipogenicprogenitordependentfibrosis
AT temponigiulia selectiveablationofnfixinmacrophagesattenuatesmusculardystrophybyinhibitingfibroadipogenicprogenitordependentfibrosis
AT messinagraziella selectiveablationofnfixinmacrophagesattenuatesmusculardystrophybyinhibitingfibroadipogenicprogenitordependentfibrosis